Pharmacology
Here are entered works on the science of drugs, including their chemistry, actions, and effects. Works on the study of the properties, preparation, and uses of drugs from natural sources are entered under Pharmacognosy.
See also what's at Wikipedia, your library, or elsewhere.
Broader term:Related terms:Narrower terms:- Pharmacology -- Congresses
- Pharmacology -- Early works to 1800
- Pharmacology -- History
- Pharmacology -- Periodicals
- Biopharmaceutics
- Clinical pharmacology
- Drug development
- Drug tolerance
- Drugs -- Physiological effect
- Drugs -- Research
- Immunopharmacology
- Neuropharmacology
- Obstetrical pharmacology
- Pediatric pharmacology
- Pharmacology, Experimental
- Psychopharmacology
- Veterinary pharmacology
- Drug effects
- Medical pharmacology
![[Info]](https://onlinebooks.library.upenn.edu/info.gif)
Medicines by Design (Bethesda, MD: National Institutes of Health, 2006) (illustrated HTML and PDF at NIH)- The Inefficacy of All Mercurial Preparations in the Cure of Venereal and Scorbutic Disorders, Proved from Reason and Experience: With a Dissertation on Mr. De Velnos's Vegetable Syrup, Which Radically Cures Every Species of The Above Disorders; And an Accurate Analysis of That Medicine (second edition, with "a refutation of Dr. Burrows' late sucrrilous pamphlet"; London: To be had of Mr. Evans, Mr. Corrall, and of Mr. Southern, 1776), by Henry Saffory (page images at NIH)
- A Manual of Materia Medica and Pharmacology: Comprising All Organic and Inorganic Drugs Which Are or Have Been Official in the United States Pharmacopoeia, Together With Important Allied Species and Useful Synthetics (4th edition; Philadelphia and New York: Lea Bros. and Co., 1906), by David M. R. Culbreth
- A Manual of Materia Medica and Pharmacology: Comprising All Organic and Inorganic Drugs Which Are or Have Been Official in the United States Pharmacopoeia, Together With Important Allied Species and Useful Synthetics (6th edition; Philadelphia and New York: Lea and Febiger, c1917), by David M. R. Culbreth (multiple formats at archive.org)
- A Manual of Organic Materia Medica and Pharmacognosy (4th edition, 1917), by Lucius Elmer Sayre (PDF files at swsbm.com)
- Behavioral Tolerance: Research and Treatment Implications, ed. by Norman A. Krasnegor (PDF at NIH)
- Problems of Drug Dependence 1994: Proceedings of the 56th Annual Scientific Meeting, The College on Problems of Drug Dependence, Inc,, by College on Problems of Drug Dependence
- Behavioral Tolerance: Research and Treatment Implications, ed. by Norman A. Krasnegor (PDF at NIH)
- Lectures of Pharmacy: Exhibiting Exact Rules for Prescribing (London: Printed for J. Noon, 1744), by Hieronymus David Gaubius (page images at NIH)
- Observations on the Present State, of the Late Dr. Ward's Medicines; To Which is Added an Account (from Experience) of Their Real Virtues and Efficacy (ca. 1775), by J. White (page images at NIH)
- Pharmaceutice Rationalis, Sive, Diatriba de Medicamentorum Operationibus in Humano Corpore (third edition, in Latin; Oxford, UK: E Theatro Sheldoniano, prostant apud. Ric. Davis, 1679), by Thomas Willis (page images at NIH)
- The Eclectic Alkaloids, Resins, Resinoids, Oleo-Resins and Concentrated Principles (1910), by John Uri Lloyd (PDF at swsbm.com)
- British Journal of Pharmacology (partial serial archives)
- Ars Pharmaceutica (in Spanish) (full serial archives)
- BMC Pharmacology and Toxicology (2012-) (full serial archives)
- BMC Pharmacology (2001-2012) (full serial archives)
- Frontiers in Pharmacology (2010-) (full serial archives)
- Journal of Pharmacy and Pharmaceutical Sciences (issues online 2007-) (partial serial archives)
- British Journal of Pharmacology and Chemotherapy (full serial archives)
- The Journal of Pharmacology and Experimental Therapeutics (partial serial archives)
- Molecular Interventions (full serial archives)
- The American Journal of Pharmacy (partial serial archives)
- BMC Clinical Pharmacology (2001-2012) (full serial archives)
- Psychedelic Review (full serial archives)
- Drug Bioequivalence (1974), by United States Congress Office of Technology Assessment (PDF files at Princeton)
- Bioavailability of Drugs to the Brain and Blood-Brain Barrier, ed. by Jerry Frankenheim and Roger M. Brown (PDF at NIH)
- Medicines by Design (Bethesda, MD: National Institutes of Health, 2006) (illustrated HTML and PDF at NIH)
- Postmarketing Surveillance of Prescription Drugs (1982), by United States Congress Office of Technology Assessment
- Drug Bioequivalence (1974), by United States Congress Office of Technology Assessment (PDF files at Princeton)
- Testing Drugs for Physical Dependence Potential and Abuse Liability, ed. by Joseph V. Brady and Scott E. Lukas (PDF at NIH)
- Suggestions for the Proving of Drugs on the Healthy: Report of the Committee Appointed for That Purpose (1853), by American Provers' Union (page images at HathiTrust)
- Federal Regulation of Methadone Treatment (1995), ed. by Richard A. Rettig and Adam Yarmolinsky (page images with commentary at NAP)
- Challenges to Tackling Antimicrobial Resistance: Economic and Policy Responses (Cambridge, UK et al.: Cambridge University Press, c2019), ed. by Michael Anderson, Michele Cecchini, and Elias Mossialos (HTML and PDF files with commentary at Cambridge University Press)
- Challenges to Tackling Antimicrobial Resistance: Economic and Policy Responses (Cambridge, UK et al.: Cambridge University Press, c2019), ed. by Michael Anderson, Michele Cecchini, and Elias Mossialos (HTML and PDF files with commentary at Cambridge University Press)
- Drug-Acceptor Interactions (c2008), by Niels Bindslev (PDF and illustrated HTML in Canada)
- An Analysis of Marijuana Policy, by National Research Council Committee on Substance Abuse and Habitual Behavior (page images with commentary at NAP)
- Drug-Acceptor Interactions (c2008), by Niels Bindslev (PDF and illustrated HTML in Canada)
- Postmarketing Surveillance of Prescription Drugs (1982), by United States Congress Office of Technology Assessment
- Current Research on the Consequences of Maternal Drug Abuse, ed. by Theodore M. Pinkert (PDF files at NIH)
- Biological Mechanisms and Perinatal Exposure to Drugs, ed. by Pushpa Thadani (PDF at NIH)
- Behavioral Studies of Drug-Exposed Offspring: Methodological Issues in Human and Animal Research, ed. by Cora Lee Wetherington, Vincent L. Smeriglio, and Loretta P. Finnegan (PDF files at NIH)
- Biological Mechanisms and Perinatal Exposure to Drugs, ed. by Pushpa Thadani (PDF at NIH)
- Impacts of Antibiotic-Resistant Bacteria (1995), by United States Congress Office of Technology Assessment
- The Effects on Human Health of Subtherapeutic Use of Antimicrobials in Animal Feeds (1980), by Assembly of Life Sciences (page images at NAP)
- The Resistance Phenomenon in Microbes and Infectious Disease Vectors: Implications for Human Health and Strategies for Containment (2003), ed. by Stacey Knobler, Stanley M. Lemon, Marjan Najafi, and Tom Burroughs (page images with commentary at NAP)
- Challenges to Tackling Antimicrobial Resistance: Economic and Policy Responses (Cambridge, UK et al.: Cambridge University Press, c2019), ed. by Michael Anderson, Michele Cecchini, and Elias Mossialos (HTML and PDF files with commentary at Cambridge University Press)
- Challenges to Tackling Antimicrobial Resistance: Economic and Policy Responses (Cambridge, UK et al.: Cambridge University Press, c2019), ed. by Michael Anderson, Michele Cecchini, and Elias Mossialos (HTML and PDF files with commentary at Cambridge University Press)
- Pharmaceutical R&D: Costs, Risks, and Rewards (OTA-H-522; 1993), by United States Congress Office of Technology Assessment (page images at HathiTrust)
- Developing New Contraceptives: Obstacles and Opportunities (1990), ed. by Luigi Mastroianni, Peter J. Donaldson, and Thomas T. Kane (page images with commentary at NAP)
- Neurobiology of Huntington's Disease: Applications to Drug Discovery (Boca Raton: CRC Press, 2011), ed. by Donald C. Lo and Robert E. Hughes (illustrated HTML at NIH)
More items available under narrower terms.